Back

News

Learn more about our company, latest developments in clinical diagnostics, and scientific breakthroughs in the rare disease field. Stay on top, subscribe to our newsletter and follow us on social media.

  1. Home
  2. Company
  3. News

News


Second Consecutive Quarter of Core Business Growth, Phasing Out COVID-19 Testing and Restructuring Organization for Core...


CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, November 18, 2021 (GLOBE NEWSWIRE) - Centogene N.V. (Nasdaq: CNTG), a...


Providing Global Clinical Trial Support for Thalassemia and Sickle Cell Disease Will Deepen Understanding of Disease...


CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, October 28, 2021 (GLOBE NEWSWIRE) 

  • FTD is a rapidly progressing...

Combining Expertise to Advance Precision Medicine, While Enabling a More Efficient and Timely Diagnosis of Rare...


CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 29, 2021 (GLOBE NEWSWIRE)

  • Collaborative research utilized...

Strong Revenues and Steady Return to Core Business Growth; Surpasses Milestone of 200 Scientific Publications,...


CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, September 1, 2021 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG),...


CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, July 27, 2021 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a...